Underlying clinical conditions and invasive pneumococcal disease (IPD) in adults in Spain (ODIN study, 2010-2012)

A. Torres, M. Rodríguez-Créixems, I. Grau, L. Molinos, P. Llinares, J. L. De la Cruz, O. Rajas, I. Alfageme, M. Salavert, A. Fenoll, J. Liñares, I. Cifuentes (Barcelona, Madrid, Oviedo, A Coruña, Málaga, Sevilla, Valencia, Spain)

Source: Annual Congress 2013 –Recent developments in pneumonia
Session: Recent developments in pneumonia
Session type: Oral Presentation
Number: 5051
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Torres, M. Rodríguez-Créixems, I. Grau, L. Molinos, P. Llinares, J. L. De la Cruz, O. Rajas, I. Alfageme, M. Salavert, A. Fenoll, J. Liñares, I. Cifuentes (Barcelona, Madrid, Oviedo, A Coruña, Málaga, Sevilla, Valencia, Spain). Underlying clinical conditions and invasive pneumococcal disease (IPD) in adults in Spain (ODIN study, 2010-2012). Eur Respir J 2013; 42: Suppl. 57, 5051

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Influence of comorbidities in the clinical presentation of invasive pneumococcal disease (IPD) in adults in Spain, 2010-2013. The ODIN study
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Clinical presentations and serotypes causing invasive pneumococcal disease in adults vaccinated with the 23-valent polysaccharide pneumococcal vaccine (PPV23) in Spain. The ODIN study (2010-2013)
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Late Breaking Abstract: Results of the first year of the "population-based nationwide surveillance of invasive pneumococcal disease (IPD) among adults >50 years old in Belgium" (2009-2010)
Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Year: 2010

Characteristics of patients under treatment for NTM disease during the period 2004-2013 in Greece
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014

RSV hospitalization in cystic fibrosis in the Canadian registry of palivizumab (CARESS) following prophylaxis (2005-2012)
Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children
Year: 2013


Risk of hospitalization due to pneumococcal pneumonia in adults in Spain. The CORIENNE study
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015


Incidence and outcomes of hospitalized for COPD exacerbations with and without pneumonia, 2006-2012: A nationwide cohort study
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

The burden of hospitalized all-cause and pneumococcal pneumonia in Spain (2010)
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013


Comorbidity and mortality in Swedish asthma patients 2006 – 2013 - An observational register study (PACEHR)
Source: International Congress 2016 – Asthma management in primary care
Year: 2016

Analysis of nontuberculous mycobacteriosis deaths in official statistics, 1970-2010, and a recent clinical cohort study for the estimation of prevalence rate in Japan
Source: Annual Congress 2013 –Interesting research questions
Year: 2013


Pneumococcal carriage and serotypes distribution in patients with acute otitis media in Switzerland, 2004-2014
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016


Hospitalization for pneumonia in the Veneto Region (North-East Italy), 2004-2012
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


COPD in northern Sweden 1994-2009: Less under-diagnosis and altered risk factor pattern
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Plaque-related vs. plaque-unrelated cardio and cerebrovascular events (CCVE) in hospitalized patients with community-acquired pneumonia (CAP): Preliminary results from the FAILCAP study (ClinicalTrials: NCT01143155)
Source: International Congress 2014 – Immunology of respiratory infections
Year: 2014


Hospitalization, mortality and vaccine effectiveness in a group of chronic obstructive pulmonary disease (COPD) patients during influenza season 1999 - 2000
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001

Magnitude and characteristics of COPD mortality in Kenya, 2012-2016
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018

RSV hospitalization in infants with neuromuscular disease in the Canadian registry of palivizumab after prophylaxis (2005-2012)
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013


Recurrence of tuberculosis into 2 years after new pulmonary TB cases curred. An observational study 2000-2005, Iasi, Romania
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008


National trends in utilization and outcomes of percutaneous coronary intervention (PCI) among patients with and without COPD in Spain (2001-2011)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

In-hospital disease burden of sarcoidosis in Switzerland from 2002 to 2012
Source: International Congress 2016 – Epidemiological aspects of tuberculosis and other respiratory conditions: from lung cancer to late-onset Pompe's disease
Year: 2016